A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Parkinson’s Disease is a progressive neurological disorder that will eventually lead to a late or end‑stage with severe ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Autism spectrum disorder is tied to an increased risk for Parkinson disease, even after adjusting for depression and antipsychotic/antidepressant use.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

In Burkina Faso, access to eye care is a challenge. Dr. Claudette Yaméogo is the only ophthalmologist who specializes in ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

One of the common motor symptoms of Parkinson’s disease (PD) is bradykinesia. Automated bradykinesia assessment is critically needed for helping neurologists achieve objective clinical diagnosis and ...

Rigidity is a key motor symptom of Parkinson's disease (PD). Clinical evaluation typically involves tools like the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), but ...